The functions and mechanisms of RNA modification in prostate: Current status and future perspectives

Front Genet. 2024 May 10:15:1380746. doi: 10.3389/fgene.2024.1380746. eCollection 2024.

Abstract

The increasing incidence and mortality of prostate cancer worldwide significantly impact the life span of male patients, emphasizing the urgency of understanding its pathogenic mechanism and associated molecular changes that regulate tumor progression for effective prevention and treatment. RNA modification, an important post-transcriptional regulatory process, profoundly influences tumor cell growth and metabolism, shaping cell fate. Over 170 RNA modification methods are known, with prominent research focusing on N6-methyladenosine, N7-methylguanosine, N1-methyladenosine, 5-methylcytidine, pseudouridine, and N4-acetylcytidine modifications. These alterations intricately regulate coding and non-coding RNA post-transcriptionally, affecting the stability of RNA and protein expression levels. This article delves into the latest advancements and challenges associated with various RNA modifications in prostate cancer tumor cells, tumor microenvironment, and core signaling molecule androgen receptors. It aims to provide new research targets and avenues for molecular diagnosis, treatment strategies, and improvement of the prognosis in prostate cancer.

Keywords: AR; CRPC; RNA modification; prostate cancer; tumor microenvironment.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported in part by a grant from the National Natural Science Foundation of China, Youth Project (No.82203505); National Key Research and Development Program of China (2022YFB3804504); National Natural Science Foundation of China, Youth Project (No.82101838, No.82203367); Experimental Animal Fund of Shanghai Science and Technology Commission (No.22140903800).